Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

epicatechin gallate/vėžys

Nuoroda įrašoma į mainų sritį
10 rezultatus

Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION The present invention relates to a nutrient pharmaceutical formulation and its use for the treatment of cancer. More specifically, the present invention relates to polyphenol containing pharmaceutical formulations having an effective amount of polyphenols for the treatment of

Tea catechins as cancer specific proliferation inhibitors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
1. INTRODUCTION The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and

Tea catechins as cancer specific proliferation inhibitors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
1. INTRODUCTION The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and

Tea catechins in sustained release formulations as cancer specific proliferation inhibitors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
1. INTRODUCTION The present invention relates to novel methods and sustained release compositions which utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not Applicable REFERENCE TO SEQUENCE LISTING, A TABLE, OR A COMPUTER PROGRAM LISTING COMPACT DISK APPENDIX Not Applicable BACKGROUND OF THE INVENTION The present invention relates to novel methods and compositions which utilize

Polyphenol inhibition of nucleoside diphosphate kinase-B activity and cancer metastasis

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of pharmacology and tumor biology. More specifically, the present invention relates to secretion of nucleoside diphosphate kinase (NDPK) from human tumors and the effects of inhibiting

Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
1. INTRODUCTION The present invention relates to novel methods and compositions which utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea leaves, in

Method of treating topical angiogenesis-related disorders

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION The invention relates to cosmetic and pharmaceutical treatment methods. More specifically, the invention relates to treatment of angiogenesis-related disorders, particularly skin disorders. BACKGROUND OF THE INVENTION Angiogenesis, which is the process of producing new

Polyphenol coxib combinations and methods

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION The field of the invention is pharmaceutical agents for treatment and chemoprevention of neoplastic diseases. BACKGROUND OF THE INVENTION Green tea extracts and their isolated constituents have been described in numerous reports as antineoplastic agents. For example, U.S. Pat.

Tea catechin formulations and processes for making same

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
1. INTRODUCTION The present invention relates to novel compositions of catechins, including but not limited to, epigallocatechin gallate (EGCg), the major catechin in green tea leaves, epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea
Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge